Zucara Therapeutics Receives Cash Injection to Advance Novel Diabetes Drug Therapy to Prevent Hypoglycemia

Corporate Breaking News

Home : Zucara Therapeutics Receives Cash Injection to Advance Novel Diabetes Drug Therapy to Prevent Hypoglycemia

Nov 04 2016	Zucara Therapeutics Receives Cash Injection to Advance Novel Diabetes Drug Therapy to Prevent Hypoglycemia
VANCOUVER, BC and TORONTO, ON--(Marketwired - November 03, 2016) - Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, announced it has received a $525,000 investment from Canadian partners: Accel-Rx Health Sciences Accelerator, The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI).


Source:http://www.marketwired.com/mw/release.do?id=2172617&sourceType=3

Related News
» Top Strike Resources Corp. Announces Termination of Proposed Transaction » Corporation Capital Quinto Real complète un placement privé totalisant 234 000 $